Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about NEUROINFLAMMATORY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | NEUROINFLAMMATORY |
| Key Genes/Proteins | C1Q, SYNA |
| Related Pathways | COMPLEMENT |
graph TD
NEUROINFLAMMATORY["NEUROINFLAMMATORY"]
P2RY12["P2RY12"] -.biomarker for.-> NEUROINFLAMMATORY
TMEM119["TMEM119"] -.biomarker for.-> NEUROINFLAMMATORY
GAIN["GAIN"] -.biomarker for.-> NEUROINFLAMMATORY
TREM2["TREM2"] -.biomarker for.-> NEUROINFLAMMATORY
NEUROINFLAMMATION["NEUROINFLAMMATION"] -.biomarker for.-> NEUROINFLAMMATORY
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| NEUROINFLAMMATORY
COMPLEMENT["COMPLEMENT"] -->|"inhibits"| NEUROINFLAMMATORY
NF__B["NF-KappaB"] -->|"activates"| NEUROINFLAMMATORY
C1Q["C1Q"] -->|"inhibits"| NEUROINFLAMMATORY
ANXIETY["ANXIETY"] -->|"activates"| NEUROINFLAMMATORY| Target | Relation | Type | Str |
|---|---|---|---|
| disease | activates | disease | 0.50 |
| CYTOKINE | activates | concept | 0.50 |
| FLAVONOIDS | regulates | concept | 0.50 |
| GLUCOSE METABOLISM | regulates | concept | 0.50 |
| GENE EXPRESSION | regulates | concept | 0.50 |
| disease | causes | disease | 0.50 |
| CYTOKINE | associated_with | concept | 0.50 |
| CYTOKINE | inhibits | concept | 0.50 |
| CELL DEATH | regulates | concept | 0.50 |
| Microbiota | associated_with | process | 0.50 |
| Gut Microbiota | associated_with | process | 0.50 |
| Hippocampus | activates | entity | 0.50 |
| Cognitive Impairment | activates | phenotype | 0.50 |
| Spinal Cord | activates | cell_type | 0.50 |
| SPINAL CORD INJURY | activates | concept | 0.50 |
| Macrophage | interacts_with | cell_type | 0.50 |
| Endothelial Cell | interacts_with | cell_type | 0.50 |
| Bipolar | interacts_with | disease | 0.50 |
| ENDOTHELIAL | interacts_with | concept | 0.50 |
| Calcium Signaling | expressed_in | pathway | 0.50 |
| GLIAL CELL ACTIVATION | activates | concept | 0.50 |
| MACROPHAGES | associated_with | concept | 0.50 |
| MONOCYTES | associated_with | concept | 0.50 |
| ALZHEIMER'S | associated_with | concept | 0.50 |
| PARKINSON'S | associated_with | concept | 0.50 |
| Microbiota | regulates | process | 0.50 |
| Gut Microbiota | regulates | process | 0.50 |
| Microbiota | activates | process | 0.50 |
| Chaperone | inhibits | pathway | 0.50 |
| Proteins | inhibits | protein | 0.50 |
| IPSC | associated_with | concept | 0.50 |
| NEURODEGENERATIVE DISEASE | activates | concept | 0.50 |
| Type 2 Diabetes | activates | disease | 0.50 |
| INSULIN | activates | concept | 0.50 |
| NEURODEGENERATIVE DISEASE | associated_with | concept | 0.50 |
| disease | regulates | disease | 0.50 |
| CARDIOVASCULAR DISEASE | interacts_with | concept | 0.50 |
| MAPK SIGNALING | inhibits | concept | 0.50 |
| disease | interacts_with | disease | 0.50 |
| disease | associated_with | disease | 0.50 |
| CEREBROSPINAL FLUID | associated_with | concept | 0.50 |
| cGAS-STING pathway | activates | pathway | 0.50 |
| Nlrp3 Inflammasome | activates | pathway | 0.50 |
| Macrophage | activates | cell_type | 0.50 |
| MACROPHAGES | activates | concept | 0.50 |
| ALZHEIMER'S | interacts_with | concept | 0.50 |
| ALZHEIMER'S | activates | concept | 0.50 |
| APP/PS1 | inhibits | concept | 0.50 |
| AXON | associated_with | concept | 0.50 |
| ISCHEMIC | associated_with | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GFAP | expressed_in | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| PYROPTOSIS | protects_against | gene | 0.60 |
| CYTOKINES | expressed_in | gene | 0.60 |
| NLR | activates | gene | 0.60 |
| APP/PS1 | inhibits | gene | 0.60 |
| MAPK | inhibits | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| BRAIN INJURY | protects_against | gene | 0.60 |
| DEMENTIA | associated_with | gene | 0.60 |
| MITOCHONDRIA | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | protects_against | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | protects_against | gene | 0.60 |
| APOPTOSIS | protects_against | gene | 0.60 |
| PARKINSON'S DISEASE | protects_against | gene | 0.60 |
| PARKINSON | protects_against | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| AND | protects_against | gene | 0.60 |
| OXIDATIVE STRESS | inhibits | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| HUNTINGTON | protects_against | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| BRAIN INJURY | associated_with | gene | 0.60 |
| PROINFLAMMATORY CYTOKINES | activates | gene | 0.60 |
| PARKINSON'S DISEASE | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | protects_against | gene | 0.60 |
| DEMENTIA | activates | gene | 0.60 |
| DISEASE-ASSOCIATED MICROGLIA | activates | gene | 0.60 |
| TAU PATHOLOGY | activates | gene | 0.60 |
| AMYLOID | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | protects_against | gene | 0.60 |
| CGAS-STING | activates | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| ALZHEIMER | protects_against | gene | 0.60 |
| OPTN | interacts_with | gene | 0.60 |
| SQSTM1 | interacts_with | gene | 0.60 |
| OPTINEURIN | interacts_with | gene | 0.60 |
| NEMO | interacts_with | gene | 0.60 |
| NF-ΚB | interacts_with | gene | 0.60 |
| OXIDATIVE STRESS | interacts_with | gene | 0.60 |
| MITOCHONDRIA | interacts_with | gene | 0.60 |
| MITOPHAGY | interacts_with | gene | 0.60 |
| PARKIN | interacts_with | gene | 0.60 |
| P62 | interacts_with | gene | 0.60 |
| DEMENTIA | inhibits | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| APP | inhibits | gene | 0.60 |
| CRH | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Resveratrol protection against renal I/R injury in diabetic rats | validation | diabetic nephropathy | 0.900 | 0.00 | streptozotocin-induced diabeti | proposed | N/A |
| AGE-mediated HCC induction in animal models with β-catenin signaling | validation | Hepatocellular carcinoma | 0.900 | 0.00 | animal models (species not spe | proposed | N/A |
| TLR expression analysis in Parkinson's disease patients | clinical | Parkinson's disease | 0.850 | 0.00 | human patients | proposed | N/A |
| Resveratrol effects on HK-2 cells under hypoxia/reoxygenation | exploratory | diabetic nephropathy | 0.850 | 0.00 | HK-2 cells cultured in high gl | proposed | N/A |
| TLR4 Activation Assay with NETs and Anti-CarP Antibodies | exploratory | rheumatoid arthritis | 0.850 | 0.00 | HEK293 TLR4 reporter cells | proposed | N/A |
| TLR expression in α-synuclein overexpressing mice | validation | Parkinson's disease | 0.800 | 0.00 | mice overexpressing human α-sy | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Ca [PMID:35642214] | Wang M, Pan W, Xu Y, Zhang J, Wan J, Jia | J Inflamm Res | 2022 | 1 |
| Decoding cell death signals in liver inflammation. [PMID:23567086] | Brenner C, Galluzzi L, Kepp O, Kroemer G | J Hepatol | 2013 | 1 |
| Podocyte TLR4 deletion alleviates diabetic kidney disease through prohibiting PK [PMID:40659086] | Li Z, Tan D, Lin J, Zhang T, Liu B et al | J Adv Res | 2026 | 0 |
| Celastrol treatment attenuates the inflammatory response in Alzheimer's disease [PMID:40762111] | Cao F, Zhang P, Zheng Z, Wang P, Wang Y | Neurol Res | 2026 | 0 |
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| CircCramp1l targets the miR-532-3p/HMGB1/Drp1 axis to regulate allergic rhinitis [PMID:41519399] | Zhang Y, Wang J, Song Y, Chai J, Li L et | Biochem Pharmacol | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Wnt-dependent modulation of alveolar epithelial phenotypes and barrier function [PMID:41678947] | Lin YC, Igarashi M, Sakai Y, Nishikawa M | Biochem Biophys Res Commun | 2026 | 0 |
| Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081] | Qin H, Yang L, Du J, Xu X, Chen Z et al. | Int Immunopharmacol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| 2'-Fucosyllactose Alleviates Metabolic Hypertension in Mice via Gut Microbiota M [PMID:41926238] | Chen J, Liang S, Liu D, Yang S, Yan Q et | J Agric Food Chem | 2026 | 0 |
| Leveraging intraperitoneal delivery of toll-like receptor agonists to treat peri [PMID:41926324] | Yan H, Chia D, Ernst S, Demuytere J, Cos | Expert Opin Drug Deliv | 2026 | 0 |
| Small-molecule PCSK9 inhibition enhances BBB amyloid-β clearance and suppresses [PMID:41927877] | Miao J, Wang J, Zhou W, Guo J | Sci Rep | 2026 | 0 |
| Anti-carbamylated protein antibodies stabilize carbamylated Histone H3 to promot [PMID:41930627] | Nakabo S, Hanata N, Patino-Martinez E, H | Arthritis Rheumatol | 2026 | 0 |
| In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV- [PMID:41931545] | Zheng N, Xu Y | PLoS Negl Trop Dis | 2026 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning NEUROINFLAMMATORY in their description or question text
Score: 0.613 · neurodegeneration · 2026-04-02
## Mechanistic Overview Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuroinflammatory Cascade starts from the
Score: 0.577 · neurodegeneration · 2026-04-20
**Molecular Mechanism and Rationale** The molecular foundation of this biomarker panel centers on the intricate interpl
Score: 0.513 · neuroinflammation · 2026-04-14
## Mechanistic Overview GAS6/TAM Axis Activation Stabilizes Blood-Brain Barrier to Reduce Neuroinflammatory Cell Infiltr
Score: 0.496 · neuroinflammation · 2026-04-21
## Mechanistic Overview Temporal NLRP3 Inhibition via SPP1-Mediated Mitophagy Enhancement During Critical Neuroinflammat
Score: 0.447 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocytic SPP1 Modulation for Neuroinflammatory Resolution starts from the claim that modulatin
Score: 0.105 · neurodegeneration · 2026-04-18
## Mechanistic Overview CD300f Immunoglobulin Receptor as Neuroinflammatory Brake starts from the claim that modulating
Score: 0.105 · neurodegeneration · 2026-04-18
## Mechanistic Overview P2RX7-PANX1 Channel Blockade for Neuroinflammatory Cascade Interruption starts from the claim th
Score: 0.000 · lipidomics · 2026-04-26
This hypothesis proposes that selective LXRβ agonism primarily functions through transcriptional upregulation of ABCA1 (
Score: 0.000 · Alzheimer's Disease · 2026-04-26
ACSL4 (acyl-CoA synthetase long-chain family member 4) drives neuroinflammatory amplification in disease-associated micr